Hear from James Hargreaves, Professor in Epidemiology and Evaluation as he delivers his inaugural lecture on “On the edge: Mixing methods, disciplines and sectors in pursuit of public health”.
Date: Thursday 23 January 2020
Location: John Snow, Keppel Street
Combating infectious diseases in Africa requires a range of approaches. The response to HIV/AIDS, for example, has shown that researchers must mix methods and involve a range of scientific disciplines and sectors in order to generate insights that can improve lives in the real world.
In this inaugural lecture, Prof James Hargreaves reflects on his career to date focused on understanding the behavioural and social determinants of infectious disease in Africa, and evaluating what can be done to prevent and treat infections. This work has often been “on the edge”: combining statistical methods with insights from in-depth interviews; working as an epidemiologist alongside colleagues in anthropology, sociology and economics; and collaborating with partners outside academia and the health sector.
Prof James Hargreaves (BSc, MSc, PhD) first gained a degree in Pharmacology and subsequently worked in clinical trials for several years. In 1997, he came to LSHTM to study epidemiology and after his MSc moved to South Africa where he was based for several years. He was the founding Director of the LSHTM Centre for Evaluation, and is Director of the international MeSH Consortium, funded by the Bill and Melinda Gates Foundation, which supports countries in Africa to use data to improve the impact of their HIV prevention and treatment programmes. He has worked on studies in South Africa, Zambia, Zimbabwe, Tanzania, Malawi, Kenya, Nigeria, Ethiopia, UK and a range of other settings. He has published more than 130 articles on subjects as diverse as HIV prevention, adolescent health, family planning, tuberculosis control, school-based deworming, the health benefits of general school education, prevention of intimate partner violence, social welfare programmes, health inequalities, HIV stigma, medical male circumcision and the HIV prevention cascade framework.